C82.58 Diffuse follicle center lymphoma, lymph nodes of multiple sites

Name of the Condition

• Diffuse Follicle Center Lymphoma, Lymph Nodes of Multiple Sites

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. When involving lymph nodes of multiple sites, the condition may present with widespread lymph node involvement, potentially affecting various regions of the body. Clinical behavior can range from indolent to more aggressive forms.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless swelling of lymph nodes in multiple areas.
• Fatigue.
• Night sweats.
• Unexplained weight loss.
• Fever.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected lymph nodes to confirm the presence and subtype of lymphoma. Additional tests may be performed to assess the extent of lymph node involvement across multiple sites.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
• Radiation therapy: Targeted treatment for localized disease.
• Chemotherapy: Systemic treatment to address widespread lymph node involvement.
• Immunotherapy: Therapies that enhance the immune system's ability to target cancer cells.
• Stem cell transplant: Considered for aggressive or relapsed cases.

Prognosis and Follow-Up

Prognosis depends on factors such as the extent of lymph node involvement, the subtype of lymphoma, and the patient's overall health. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or progression. Treatment response and long-term outcomes vary based on individual circumstances.

Complications

• Progressive lymph node enlargement leading to organ compression.
• Increased risk of infections due to impaired immune function.
• Potential transformation to a more aggressive lymphoma subtype.
• Treatment-related side effects, such as fatigue or organ toxicity.

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health.
• Avoid known carcinogens and limit alcohol consumption.
• Stay up-to-date with vaccinations to reduce infection risk.
• Manage stress through relaxation techniques or support groups.

When to Seek Professional Help

Seek medical attention if you experience persistent, unexplained lymph node swelling, unexplained weight loss, night sweats, or fatigue. Prompt evaluation is important for early diagnosis and treatment planning.

Tips for Medical Coders

When coding for diffuse follicle center lymphoma involving lymph nodes of multiple sites, ensure documentation specifies the involvement of multiple lymph node regions. Code C82.58 is appropriate for this scenario. Verify that the diagnosis aligns with the clinical findings and that supporting documentation (e.g., biopsy reports, imaging) confirms the extent of lymph node involvement. Accurate coding requires clear differentiation from single-site or unspecified lymph node involvement.